Morgan Stanley Unveils Top Equity Picks for 2026, Spotlighting Growth Catalysts

Morgan Stanley has curated a select list of five stocks poised for outperformance by 2026, emphasizing undervalued opportunities with near-term catalysts. Affirm Holdings leads the pack, deemed undervalued by analyst James Faucette despite market skepticism around its private credit exposure. The buy-now-pay-later fintech could see momentum from its May 12 investor forum and Q3 fiscal 2026 results.

UnitedHealth Group joins the roster after surpassing Q1 earnings expectations and securing favorable Medicare Advantage rate adjustments. Meta Platforms emerges as the preferred big tech play ahead of its April 29 earnings, while CrowdStrike claims the software crown with $5B annual recurring revenue and accelerating growth. Seagate rounds out the selections, favored over Western Digital for margin expansion and AI-driven storage demand.